Mohammad Bilal Alsavaf
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mohammad Bilal Alsavaf has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Moataz D. Abouammo
Department of Otorhinolaryngology, The Ohio State University and Wexner Medical Centre, Columbus, Ohio, USA
7 shared publications - Ricardo L. Carrau
Department of Otolaryngology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
6 shared publications - Daniel M. Prevedello
Department of Neurological Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
5 shared publications Ricardo L. Carrau
Department of Otolaryngology-Head and Neck Surgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA
5 shared publicationsDaniel M. Prevedello
Neurological Surgery The Ohio State University Columbus Ohio USA
4 shared publications- Guilherme Mansur
Department of Neurological Surgery, Wexner Medical Center at The Ohio State University, Columbus, Ohio, USA
4 shared publications
Latest Publications
- 12 June 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 31 (5) , 999
Endoscopic Endonasal Transorbital Extracapsular Resection of an Intraorbital Intraconal Capillary Hemangioma: A 3-Dimensional Operative Video
- 12 June 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 31 (5) , 999
Endoscopic Endonasal Transorbital Extracapsular Resection of an Intraorbital Intraconal Capillary Hemangioma: A 3-Dimensional Operative Video
- Open Access
- 30 May 2025
- Published by Marmara University in Marmara Medical Journal
- Vol. 38 (2) , 182-185
Successful Treatment of Temporal Bone Langerhans Cell Histiocytosis with Oral Steroids: A Case Report
Langerhans cell histiocytosis (LCH) is a rare disease; treatment recommendations are based on organ involvement and the extent of the disease. We present a patient with a solitary lesion of LCH with BRAF-V600K mutation which was successfully managed with systemic steroids and followed up for a long time. A 39-year-old man presented with persistent right otitis media with effusion despite treatment. LCH was diagnosed by punch biopsy, and temporal computed tomography (CT) showed an invasive, enhancing soft tissue mass extending from the malleolus to the epitympanic recess. Due to the patient’s young age and the localization of the lesion, radiation and surgery were not considered. The patient was treated with systemic methylprednisolone. The patient’s symptoms resolved after treatment and the tumor regressed completely. The case had a good prognosis in the 5-year period. This is the first report of a LCH case with the BRAF-V600K mutation, highlighting a unique aspect of the disease. The successful therapy of the temporal bone LCH with systemic steroids alone, underscores the potential effect of this treatment for the management of unifocal lesions in critical locations. Further studies and case reports are needed to expand our understanding of LCH and explore optimal therapeutic approaches for different mutation subtypes.
- 30 May 2025
- Published by Marmara University in Marmara Medical Journal
- Vol. 38 (2) , 182-185
Open AccessSuccessful Treatment of Temporal Bone Langerhans Cell Histiocytosis with Oral Steroids: A Case Report
Langerhans cell histiocytosis (LCH) is a rare disease; treatment recommendations are based on organ involvement and the extent of the disease. We present a patient with a solitary lesion of LCH with BRAF-V600K mutation which was successfully managed with systemic steroids and followed up for a long time. A 39-year-old man presented with persistent right otitis media with effusion despite treatment. LCH was diagnosed by punch biopsy, and temporal computed tomography (CT) showed an invasive, enhancing soft tissue mass extending from the malleolus to the epitympanic recess. Due to the patient’s young age and the localization of the lesion, radiation and surgery were not considered. The patient was treated with systemic methylprednisolone. The patient’s symptoms resolved after treatment and the tumor regressed completely. The case had a good prognosis in the 5-year period. This is the first report of a LCH case with the BRAF-V600K mutation, highlighting a unique aspect of the disease. The successful therapy of the temporal bone LCH with systemic steroids alone, underscores the potential effect of this treatment for the management of unifocal lesions in critical locations. Further studies and case reports are needed to expand our understanding of LCH and explore optimal therapeutic approaches for different mutation subtypes.
- 5 May 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 29 (6) , 865-875
Comparative Cadaveric Study and Anatomic Limitations of the Nasofrontal Trephination: A Novel Endoscopic Corridor for Enhanced Exposure of The Odontoid and Occipital Condyle Regions
BACKGROUND AND OBJECTIVES: The endoscopic endonasal approach (EEA) serves as the primary minimally invasive route to the ventral craniovertebral junction (CVJ). However, anatomic constraints limit its caudal reach. Multiport endoscopic approaches may complement a standard EEA providing additional reach. This anatomic study evaluates the EEA's anatomic limitations in accessing the CVJ and examines how contralateral nasofrontal trephination (CNT) port may overcome these constraints. METHODS: Thirty-two cadaveric specimens underwent EEA and CNT dissections. Key measurements included the nasoaxial line (NAxL) angle, anteroposterior frontal sinus distance, interorbital distance, and distance of odontoid process from the hard palate line. Area of exposure and surgical freedom were quantified using a surgical navigation. A clinical case treated using the CNT approach has been included to demonstrate the technique, instrument utilization, successful healing, and absence of complications. RESULTS: CNT significantly enhanced area of exposure of both odontoid (1720.41 vs 1086.62 mm 2 , P = <.001) and occipital condyle targets (613.32 vs 446.15 mm 2 , P = <.001), while EEA provided significant greater surgical freedom for both odontoid (1121.91 vs 1030.58 mm 3 , P = <.001) and occipital condyle (888.25 vs 827.74 mm 3 , P = <.001). Frontal sinus anteroposterior distance strongly correlated with CNT odontoid exposure (r = 0.889, P < .001) but not with the occipital condyle (r = −0.009, P = .966). CNT offered a wider angle of attack compared with EEA (49.8° vs 16.5°, P = <.001). NAxL angle inversely correlated with the distance of the odontoid process from the hard palate line level (r = −0.757, P < .001), while showing no significant correlation with EEA exposure area. CONCLUSION: CNT augments traditional EEA by enhancing inferior access during the management of complex CVJ pathologies. Although NAxL angle may provide guidance in determining the inferior extent of the EEA, anatomic variability and its poor correlation with exposure area limit its standalone utility in surgical planning.
- 5 May 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 29 (6) , 865-875
Comparative Cadaveric Study and Anatomic Limitations of the Nasofrontal Trephination: A Novel Endoscopic Corridor for Enhanced Exposure of The Odontoid and Occipital Condyle Regions
BACKGROUND AND OBJECTIVES: The endoscopic endonasal approach (EEA) serves as the primary minimally invasive route to the ventral craniovertebral junction (CVJ). However, anatomic constraints limit its caudal reach. Multiport endoscopic approaches may complement a standard EEA providing additional reach. This anatomic study evaluates the EEA's anatomic limitations in accessing the CVJ and examines how contralateral nasofrontal trephination (CNT) port may overcome these constraints. METHODS: Thirty-two cadaveric specimens underwent EEA and CNT dissections. Key measurements included the nasoaxial line (NAxL) angle, anteroposterior frontal sinus distance, interorbital distance, and distance of odontoid process from the hard palate line. Area of exposure and surgical freedom were quantified using a surgical navigation. A clinical case treated using the CNT approach has been included to demonstrate the technique, instrument utilization, successful healing, and absence of complications. RESULTS: CNT significantly enhanced area of exposure of both odontoid (1720.41 vs 1086.62 mm 2 , P = <.001) and occipital condyle targets (613.32 vs 446.15 mm 2 , P = <.001), while EEA provided significant greater surgical freedom for both odontoid (1121.91 vs 1030.58 mm 3 , P = <.001) and occipital condyle (888.25 vs 827.74 mm 3 , P = <.001). Frontal sinus anteroposterior distance strongly correlated with CNT odontoid exposure (r = 0.889, P < .001) but not with the occipital condyle (r = −0.009, P = .966). CNT offered a wider angle of attack compared with EEA (49.8° vs 16.5°, P = <.001). NAxL angle inversely correlated with the distance of the odontoid process from the hard palate line level (r = −0.757, P < .001), while showing no significant correlation with EEA exposure area. CONCLUSION: CNT augments traditional EEA by enhancing inferior access during the management of complex CVJ pathologies. Although NAxL angle may provide guidance in determining the inferior extent of the EEA, anatomic variability and its poor correlation with exposure area limit its standalone utility in surgical planning.
- 9 March 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 87 (02) , 190-199
Novel Strategies for Expanding the Endoscopic Caudal Access to the Craniovertebral Junction: A Cadaveric Comparative Analysis of Nasofrontal Trephination and Posterior Palatectomy
Although the endoscopic endonasal approach (EEA) has emerged as a preferred alternative to traditional transoral access for craniovertebral junction (CVJ) surgery, its limited inferior reach beyond the C1 level remains a significant challenge. This study investigates the effectiveness of using a contralateral nasofrontal trephination (CNT) or a posterior palatectomy (PP) to enhance the caudal reach to the CVJ region. A quantitative cadaveric study. Cadaver dissection laboratory. A total of 15 adult human cadaveric heads. EEA, EEA + PP, and EEA + CNT approaches to the CVJ were performed. Neuronavigation was used for objective measurements quantifying the volume of surgical freedom, surface area of deep exposure, entry point sagittal angle, and inferior reach below the odontoid process. EEA + CNT demonstrated superior surgical metrics across all parameters. Surface exposure was significantly greater with EEA + CNT (107.04 cm2) versus EEA + PP (86.26 cm2) and standard EEA (69.78 cm2; p < 0.001). The volume of surgical freedom showed similar superiority with EEA + CNT (60.21 cm3), followed by EEA + PP (34.14 cm3) and EEA (26.13 cm3; p < 0.001). Inferior reach below the odontoid (CNT: 6.35 cm; PP: 2.17 cm; EEA: 0.9 cm; p < 0.0001) and surgical trajectory angle (CNT: 50.1 degrees; PP: 21.4 degrees; EEA: 16.6 degrees; p < 0.0001) demonstrated significant stepwise improvements with each adjunct technique. Both CNT and PP techniques significantly enhance the surgical corridor of traditional EEA for CVJ access. A CNT afforded superior surgical exposure while maintaining minimal invasiveness. PP offers a viable alternative when external incisions are undesired and lesions are confined within the C2–C3 level. The data that support the findings of this study are available from the corresponding author upon reasonable request. This article was selected to receive the Rhoton Award at the 34th North American Skull Base Society Conference in New Orleans, Louisiana, USA, 2025. Received: 16 January 2025 Accepted: 21 March 2025 Accepted Manuscript online: 25 March 2025 Article published online: 12 May 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 9 March 2025
- Published by Georg Thieme Verlag KG in Journal of Neurological Surgery Part B: Skull Base
- Vol. 87 (02) , 190-199
Novel Strategies for Expanding the Endoscopic Caudal Access to the Craniovertebral Junction: A Cadaveric Comparative Analysis of Nasofrontal Trephination and Posterior Palatectomy
Although the endoscopic endonasal approach (EEA) has emerged as a preferred alternative to traditional transoral access for craniovertebral junction (CVJ) surgery, its limited inferior reach beyond the C1 level remains a significant challenge. This study investigates the effectiveness of using a contralateral nasofrontal trephination (CNT) or a posterior palatectomy (PP) to enhance the caudal reach to the CVJ region. A quantitative cadaveric study. Cadaver dissection laboratory. A total of 15 adult human cadaveric heads. EEA, EEA + PP, and EEA + CNT approaches to the CVJ were performed. Neuronavigation was used for objective measurements quantifying the volume of surgical freedom, surface area of deep exposure, entry point sagittal angle, and inferior reach below the odontoid process. EEA + CNT demonstrated superior surgical metrics across all parameters. Surface exposure was significantly greater with EEA + CNT (107.04 cm2) versus EEA + PP (86.26 cm2) and standard EEA (69.78 cm2; p < 0.001). The volume of surgical freedom showed similar superiority with EEA + CNT (60.21 cm3), followed by EEA + PP (34.14 cm3) and EEA (26.13 cm3; p < 0.001). Inferior reach below the odontoid (CNT: 6.35 cm; PP: 2.17 cm; EEA: 0.9 cm; p < 0.0001) and surgical trajectory angle (CNT: 50.1 degrees; PP: 21.4 degrees; EEA: 16.6 degrees; p < 0.0001) demonstrated significant stepwise improvements with each adjunct technique. Both CNT and PP techniques significantly enhance the surgical corridor of traditional EEA for CVJ access. A CNT afforded superior surgical exposure while maintaining minimal invasiveness. PP offers a viable alternative when external incisions are undesired and lesions are confined within the C2–C3 level. The data that support the findings of this study are available from the corresponding author upon reasonable request. This article was selected to receive the Rhoton Award at the 34th North American Skull Base Society Conference in New Orleans, Louisiana, USA, 2025. Received: 16 January 2025 Accepted: 21 March 2025 Accepted Manuscript online: 25 March 2025 Article published online: 12 May 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 16 February 2025
- Published by Elsevier in Oral Oncology
- Vol. 162, 107219
Dysphagia in head and neck cancer patients with evidence of esophageal dysmotility on manometry
- 16 February 2025
- Published by Elsevier in Oral Oncology
- Vol. 162, 107219
Dysphagia in head and neck cancer patients with evidence of esophageal dysmotility on manometry
- Open Access
- 14 February 2025
- Published by Elsevier in World Neurosurgery
- Vol. 195, 123682
Intra-Infundibular Epidermoid Cysts: A Distinct and Rare Entity
- 14 February 2025
- Published by Elsevier in World Neurosurgery
- Vol. 195, 123682
Open AccessIntra-Infundibular Epidermoid Cysts: A Distinct and Rare Entity
- Open Access
- 12 February 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-9
Use of intraoperative ultrasound in differentiating adamantinomatous versus papillary craniopharyngiomas and guiding resection through the endoscopic endonasal route
Craniopharyngiomas (CPs) are surgically challenging tumors. The prevalence of BRAF mutation in papillary craniopharyngioma (PCP) and the positive response with BRAF-MEK inhibitors have shifted the treatment paradigm towards targeted therapy. However, maximal safe resection remains the goal, particularly for adamantinomatous craniopharyngioma (ACP). In this report, we describe two cases of CP where intraoperative ultrasonography (IOUS) was helpful in differentiating the subtype of CP, thus enabling intraoperative decision-making regarding the extent of resection. Additionally, IOUS images of three more (two PCP and one ACP) patients who underwent endoscopic endonasal resection for CPs were retrospectively evaluated. Each of these entities showed characteristic appearances on IOUS.
- 12 February 2025
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 167 (1) , 1-9
Open AccessUse of intraoperative ultrasound in differentiating adamantinomatous versus papillary craniopharyngiomas and guiding resection through the endoscopic endonasal route
Craniopharyngiomas (CPs) are surgically challenging tumors. The prevalence of BRAF mutation in papillary craniopharyngioma (PCP) and the positive response with BRAF-MEK inhibitors have shifted the treatment paradigm towards targeted therapy. However, maximal safe resection remains the goal, particularly for adamantinomatous craniopharyngioma (ACP). In this report, we describe two cases of CP where intraoperative ultrasonography (IOUS) was helpful in differentiating the subtype of CP, thus enabling intraoperative decision-making regarding the extent of resection. Additionally, IOUS images of three more (two PCP and one ACP) patients who underwent endoscopic endonasal resection for CPs were retrospectively evaluated. Each of these entities showed characteristic appearances on IOUS.
- 20 December 2024
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
Impact of Tobacco, Marijuana, and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated With Immune Checkpoint Inhibitors
Aim: The response rates to immune checkpoint inhibitors (ICI) remain low (13%–20%) in metastatic head and neck cancer patients, indicating an urgent need to better understand factors predictive of response to these agents. This study explored the impact of smoking status, marijuana use, and alcohol consumption on treatment outcomes in recurrent‐metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients treated with ICI.Methods: A retrospective analysis was performed on 201 R/M HNSCC patients treated with ICI between January 15th 2016 and April 9th 2020 at a single institution.Results: Gender: 154 male (77%), 47 female (23%). Median age 61 (IQR: 55–68). ICI drug: pembrolizumab 100 (50%), nivolumab 91 (45%), nivolumab + ipilimumab 10 (5%). Line of therapy: first: 98 (49%), second and beyond: 103 (51%). Tumor site: oropharynx 84 (42%), oral cavity 45 (22%), larynx 26 (13%), other sites 46 (23%). p16 tumor status: negative 132 (66%), positive 69 (34%). Smoking status: former 111 (55%), never 54 (27%), current 36 (18%), median pack‐year 18 (IQR: 0–37). Alcohol use: yes 110 (55%), no 91 (54%). Marijuana use: yes 47 (23%), no 154 (77%). Overall response rate: 36 (18%). Median OS: 12 months (95% CI: 9.4–14.8). Tobacco: former (HR: 0.75, 95% CI: 0.50, 1.11), current (HR: 0.58, 95% CI: 0.33, 1.02). Marijuana: yes (HR: 0.93, 95% CI: 0.58, 1.49). Alcohol: yes (HR: 1.04, 95% CI: 0.72, 1.49).Conclusion: In our cohort, smoking status, marijuana use, and alcohol consumption did not have a statistically significant impact on OS in patients with R/M HNSCC treated with ICI.
- 20 December 2024
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
Impact of Tobacco, Marijuana, and Alcohol Use on Overall Survival in Recurrent Metastatic Head and Neck Cancer Patients Treated With Immune Checkpoint Inhibitors
Aim: The response rates to immune checkpoint inhibitors (ICI) remain low (13%–20%) in metastatic head and neck cancer patients, indicating an urgent need to better understand factors predictive of response to these agents. This study explored the impact of smoking status, marijuana use, and alcohol consumption on treatment outcomes in recurrent‐metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients treated with ICI.Methods: A retrospective analysis was performed on 201 R/M HNSCC patients treated with ICI between January 15th 2016 and April 9th 2020 at a single institution.Results: Gender: 154 male (77%), 47 female (23%). Median age 61 (IQR: 55–68). ICI drug: pembrolizumab 100 (50%), nivolumab 91 (45%), nivolumab + ipilimumab 10 (5%). Line of therapy: first: 98 (49%), second and beyond: 103 (51%). Tumor site: oropharynx 84 (42%), oral cavity 45 (22%), larynx 26 (13%), other sites 46 (23%). p16 tumor status: negative 132 (66%), positive 69 (34%). Smoking status: former 111 (55%), never 54 (27%), current 36 (18%), median pack‐year 18 (IQR: 0–37). Alcohol use: yes 110 (55%), no 91 (54%). Marijuana use: yes 47 (23%), no 154 (77%). Overall response rate: 36 (18%). Median OS: 12 months (95% CI: 9.4–14.8). Tobacco: former (HR: 0.75, 95% CI: 0.50, 1.11), current (HR: 0.58, 95% CI: 0.33, 1.02). Marijuana: yes (HR: 0.93, 95% CI: 0.58, 1.49). Alcohol: yes (HR: 1.04, 95% CI: 0.72, 1.49).Conclusion: In our cohort, smoking status, marijuana use, and alcohol consumption did not have a statistically significant impact on OS in patients with R/M HNSCC treated with ICI.
- Open Access
- 16 November 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 45 (1) , 1-2
Correction to: DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
- 16 November 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 45 (1) , 1-2
Open AccessCorrection to: DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
- Open Access
- 9 August 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (8) , 1-17
DIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
Loss of function mutations in Diaphanous related formin 1 (DIAPH1) are associated with seizures, cortical blindness, and microcephaly syndrome (SCBMS) and are recently linked to combined immunodeficiency. However, the extent of defects in T and innate lymphoid cells (ILCs) remain unexplored. Herein, we characterized the primary T, natural killer (NK) and helper ILCs of six patients carrying two novel loss of function mutation in DIAPH1 and Jurkat cells after DIAPH1 knockdown. Mutations were identified by whole exome sequencing. T-cell immunophenotyping, proliferation, migration, cytokine signaling, survival, and NK cell cytotoxicity were studied via flow cytometry-based assays, confocal microscopy, and real-time qPCR. CD4+ T cell proteome was analyzed by mass spectrometry. p.R351* and p.R322*variants led to a significant reduction in the DIAPH1 mRNA and protein levels. DIAPH1-deficient T cells showed proliferation, activation, as well as TCR-mediated signaling defects. DIAPH1-deficient PBMCs also displayed impaired transwell migration, defective STAT5 phosphorylation in response to IL-2, IL-7 and IL-15. In vitro generation/expansion of Treg cells from naïve T cells was significantly reduced. shRNA-mediated silencing of DIAPH1 in Jurkat cells reduced DIAPH1 protein level and inhibited T cell proliferation and IL-2/STAT5 axis. Additionally, NK cells from patients had diminished cytotoxic activity, function and IL-2/STAT5 axis. Lastly, DIAPH1-deficient patients’ peripheral blood contained dramatically reduced numbers of all helper ILC subsets. DIAPH1 deficiency results in major functional defects in T, NK cells and helper ILCs underlining the critical role of formin DIAPH1 in the biology of those cell subsets. Graphical Abstract
- 9 August 2024
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 44 (8) , 1-17
Open AccessDIAPH1-Deficiency is Associated with Major T, NK and ILC Defects in Humans
Loss of function mutations in Diaphanous related formin 1 (DIAPH1) are associated with seizures, cortical blindness, and microcephaly syndrome (SCBMS) and are recently linked to combined immunodeficiency. However, the extent of defects in T and innate lymphoid cells (ILCs) remain unexplored. Herein, we characterized the primary T, natural killer (NK) and helper ILCs of six patients carrying two novel loss of function mutation in DIAPH1 and Jurkat cells after DIAPH1 knockdown. Mutations were identified by whole exome sequencing. T-cell immunophenotyping, proliferation, migration, cytokine signaling, survival, and NK cell cytotoxicity were studied via flow cytometry-based assays, confocal microscopy, and real-time qPCR. CD4+ T cell proteome was analyzed by mass spectrometry. p.R351* and p.R322*variants led to a significant reduction in the DIAPH1 mRNA and protein levels. DIAPH1-deficient T cells showed proliferation, activation, as well as TCR-mediated signaling defects. DIAPH1-deficient PBMCs also displayed impaired transwell migration, defective STAT5 phosphorylation in response to IL-2, IL-7 and IL-15. In vitro generation/expansion of Treg cells from naïve T cells was significantly reduced. shRNA-mediated silencing of DIAPH1 in Jurkat cells reduced DIAPH1 protein level and inhibited T cell proliferation and IL-2/STAT5 axis. Additionally, NK cells from patients had diminished cytotoxic activity, function and IL-2/STAT5 axis. Lastly, DIAPH1-deficient patients’ peripheral blood contained dramatically reduced numbers of all helper ILC subsets. DIAPH1 deficiency results in major functional defects in T, NK cells and helper ILCs underlining the critical role of formin DIAPH1 in the biology of those cell subsets. Graphical Abstract